Amedisys Inc (AMED) Files Form 4 Insider Selling : Scott G Ginn Sells 6,000 Shares

Amedisys Inc (AMED): Scott G Ginn , officer of Amedisys Inc sold 6,000 shares on May 11, 2016. The Insider selling transaction was reported by the company on May 13, 2016 to the Securities and Exchange Commission. The shares were sold at $51.65 per share for a total value of $309,706.50 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Sep 25, 2015, Scott G Ginn (Principal Accounting Officer) sold 3,063 shares at $46.33 per share price.On Aug 19, 2015, Donald A Washburn (director) sold 20,000 shares at $45.51 per share price.Also, On Jul 31, 2015, Bruce D Perkins (director) purchased 3,000 shares at $43.07 per share price.On May 6, 2015, Peter Ricchiuti (director) sold 900 shares at $27.66 per share price.

Amedisys Inc: On Tuesday, May 10, 2016 heightened volatility was witnessed in Amedisys Inc which led to swings in the share price. The shares opened for trading at $52.51 and hit $52.51 on the upside , eventually ending the session at $51.99, with a gain of 0.58% or 0.3 points. The heightened volatility saw the trading volume jump to 2,53,969 shares. The 52-week high of the share price is $54.29 and the company has a market cap of $1,737 M . The 52-week low of the share price is at $27.67.

Amedisys Inc Money Flow Index Chart

Company has been under the radar of several Street Analysts.Amedisys Inc is Reiterated by RBC Capital Mkts to Sector Perform and the brokerage firm has raised the Price Target to $ 48 from a previous price target of $41 .The Rating was issued on May 6, 2016.Amedisys Inc is Reiterated by Mizuho to Buy and the brokerage firm has raised the Price Target to $ 57 from a previous price target of $49 .The Rating was issued on Apr 11, 2016.

Amedisys Inc. (Amedisys) is a health care at home company. Amedisys delivers home health and hospice care to more than 360000 patients each year. The Company has care network across 34 states. As of December 31 2014 it owned and operated 316 Medicare-certified home health care centers and 80 Medicare-certified hospice care centers. The Company operates through two segments: home health and hospice. The Company’s home health segment delivers a range of services in the homes of individuals who may be recovering from surgery have a chronic disability or terminal illness or need assistance with the essential activities of daily living. The Company’s hospice segment provides palliative care and comfort to terminally ill patients and their families.

Leave a Reply

Amedisys Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Amedisys Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.